Abstract
We retrospectively studied 108 marrow harvests from 105 pediatric sibling donors. The median age of donors was 8 years (range: 1–15) and the median body weight was 27 kg (range: 10–100). The volumes of aspirated marrow were 5.0–23.8 mL/kg donor body weight, and harvested bone marrow volume exceeded 15 mL/kg in 42% of the donors. A total of 100 autologous blood donations were performed, and eight donors had red cells salvaged from their harvests reinfused. The median Hb levels before and after harvests were 12.3 g/dL (range: 10.0–14.7) and 11.0 g/dL (range: 8.9–13.8), respectively. None of the donors received allogeneic blood transfusions or hematopoietic growth factors such as EPO and G-CSF before or after collection. Transplanted dose was 1.4–10.8 × 108 cells/kg recipient body weight without differences due to donor age. Higher concentrations of nucleated and CD34+ cells were obtained from younger donors. All donors tolerated the procedures well, with no serious complications. Thus, children may safely donate marrow for allogeneic transplantation, and the yields of nucleated cells for engraftment are substantial.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Miano M, Labopin M, Hartmann O, Angeluccy E, Cornish J, Gluckman E et al. Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group of Blood and Marrow Transplantation. Bone Marrow Transplant 2007; 39: 89–99.
Buckner CD, Clift RA, Sanders JE, Stewart WI, Bensinger KC, Doney KM et al. Marrow harvesting from normal donors. Blood 1984; 643: 630–634.
Sanders J, Buckner CD, Bensinger WI, Levy W, Chard R, Thomas ED . Experience with marrow harvesting from donor less than two years of age. Bone Marrow Transplant 1987; 2: 45–50.
Martinez AM, Sastre A, Munoz A, Badell I, Maldonado MS, Cubells J . Recombinant human erythropoietin (rh-Epo) administration to normal child bone marrow donors. Bone Marrow Transplant 1998; 22: 137–138.
Frangoul H, Nemecek ER, Billheimer D, Pulsipher MA, Khan S, Woolfrey A et al. A prospective study of G-CSF-primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and marrow Transplant Consortium (PBMTC) study. Blood 2007; 110: 4584–4587.
Kim H, Kang HJ, Lee JW, Park KD, Shin HY, Ahn HS . Early engraftment of G-CSF-primed allogeneic bone marrow transplantation in pediatric patients regardless of donor-recipient weight differences. Ann Hematol 2012; 91: 751–758.
Styczynski J, Balduzzi A, Gil L, Labopin M, Hamladji RM, Marktel S et al. Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Disease Working Party study. Blood 2012; 119: 2935–2942.
van Walraven SM, Straathof LM, Switzer GE, Lankester A, Korthof ET, Brand A et al. Immediate and long-term somatic effects, and health-related quality of life of BM donation during early childhood. A single-center report in 210 pediatric donors. Bone Marrow Transplant 2013; 48: 40–45.
Friebert SE, Shepardson LB, Shurin SB, Rosenthal GE, Rosenthal NS . Pediatric bone marrow cellularity: Are we expecting too much? J Pediat Hematol Oncol 1998; 20: 439–443.
Kuranda K, Vargaftig J, de la Rochere P, Dosquet C, Charron D, Bardin F et al. Age-related changes in human hematopoietic stem/progenitor cells. Aging Cell 2011; 10: 542–546.
Povsic TJ, Zhou J, Adams SD, Bolognesi MP, Attarian DE, Peterson ED . Aging is not associated with bone marrow resident progenitor cell depletion. J Gerontol A Biol Sci Med Sci 2010; 65: 1042–1050.
Pulsipher MA, Levine JE, Hayashi RJ, Chan W, Anderson P, Duerst R et al. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: The pediatric Blood and Marrow Transplant Consortium Experience (PBMTC) 1996-2003. Bone Marrow Transplant 2005; 35: 361–367.
Pulsipher MA, Nagler A, Iannone R, Nelson RM . Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: Ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr Blood and Cancer 2006; 46: 422–433.
Halter JP, van Walraven SM, Worel N, Bengtsson M, Hägglund H, Nicoloso G et al. Allogeneic hematopoietic stem cell donation: standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transplant 2013; 48: 220–225.
Lavoie J . Blood transfusion risks and alternative strategies in pediatric patients. Pediatr Anesth 2011; 21: 14–24.
Hibino N, Nagashima M, Sato H, Hori T, Ishitoya H, Tomino T . Preoperative autologous blood donation for cardiac surgery in children. Asian Cardiovasc Thorac Ann 2008; 16: 21–24.
Lauder GR . Pre-operative predeposit autologous donation in children presenting for elective surgery: a review. Transfusion Med 2006; 17: 75–82.
Masuda H, Moriyama Y, Hisatomi K, Toda R, Shimokawa S, Iguro Y et al. Preoperative autologous donation of blood for a simple cardiac anomaly: analysis of children weighing under twenty kilograms. J Thorac Cardiovasc Surg 2000; 120: 783–789.
Kletzel M, Olszewski M, Danner-Koptik K, Coyne K, Haut PR . Red cell salvage and reinfusion in pediatric bone marrow donors. Bone Marrow Transplant 1999; 24: 385–388.
Chan KW, Gajewski JL, Supkis D, Pentz R, Champlin R, Bleyer WA . Use of minors as bone marrow donors: current attitude and management. J Pediatr 1996; 128: 644–648.
Kato S, Omura A, Akiyama Y, Imaizumi S, Tsuchida M, Kawano Y et al. Committee session: Hematopoietic Stem cell Transplantation Committee. Jpn J Pediatr Hematol 2003; 17: 167–183.
Acknowledgements
We would like to thank the individual donors, patients and families in the study who made this work possible, and the members in the departments of blood transfusion service and cell transplantation and regenerative medicine of Tokai university hospital for their expert technical assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Yabe, M., Morimoto, T., Shimizu, T. et al. Feasibility of marrow harvesting from pediatric sibling donors without hematopoietic growth factors and allotransfusion. Bone Marrow Transplant 49, 921–926 (2014). https://doi.org/10.1038/bmt.2014.73
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2014.73
This article is cited by
-
One single bone marrow harvesting from donors under 3 years of age: assessing safety and efficacy of the procedure
Bone Marrow Transplantation (2019)
-
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy
Bone Marrow Transplantation (2019)